Orange Book product · Generic (ANDA)
MEDROXYPROGESTERONE ACETATE
MEDROXYPROGESTERONE ACETATE
At a glance
Nov 28, 2017
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 28, 2017
8 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
MEDROXYPROGESTERONE ACETATE
Strength
150MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AB
Application
ANDA 077235
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MEDROXYPROGESTERONE ACETATE
- 2004DEPO-SUBQ PROVERA 104Brand (NDA)
NDA 021583 · PFIZER
- 1992DEPO-PROVERABrand (NDA)
NDA 020246 · PFIZER
- —DEPO-PROVERABrand (NDA)
NDA 012541 · PFIZER
- —PROVERABrand (NDA)
NDA 011839 · PFIZER
- 2023MEDROXYPROGESTERONE ACETATEGeneric (ANDA)
ANDA 215397 · AMNEAL
- 2023MEDROXYPROGESTERONE ACETATEGeneric (ANDA)
ANDA 214309 · HIKMA
- 2022MEDROXYPROGESTERONE ACETATEGeneric (ANDA)
ANDA 212844 · EUGIA PHARMA
- 2022MEDROXYPROGESTERONE ACETATEGeneric (ANDA)
ANDA 212824 · EUGIA PHARMA
- 2019MEDROXYPROGESTERONE ACETATEGeneric (ANDA)
ANDA 210760 · SUN PHARM
- 2019MEDROXYPROGESTERONE ACETATEGeneric (ANDA)
ANDA 210761 · SUN PHARM
- 2019MEDROXYPROGESTERONE ACETATEGeneric (ANDA)
ANDA 210335 · CIPLA
- 2018MEDROXYPROGESTERONE ACETATEGeneric (ANDA)
ANDA 210227 · XIROMED
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
